Reidar Lie

本期"国际生命伦理学家"栏目介绍挪威卑尔根大学哲学系主任Reidar Lie教授。本文分三部分,第一部分是他的简历,他目前的研究方向是:国际合作研究的伦理问题,发展中国家卫生改革的伦理问题。第二部分是他提供的最新代表作"疾病监测、受益和样本共享"。文章考查了世界卫生组织内部有关建立流感大流行准备框架的争论,这个争论涉及那些贡献样本的国家能够预期有哪些受益作为回报,特别是在获得大流行的流感疫苗上,虽然在2011年达成了协议,但基本的争议问题并没有得到解决。第三部分是他就生命伦理学与科学哲学的关系、生命伦理学的规范性以及生命伦理学家了解临床和研究实践等问题所作的回答。

The column ＂ International Bioethicists＂ of this issue will introduce Professor Reidar Lie, university of Bergen in Norway. This column consists of three parts ： the first is his resume. His current interests include ethical issues in international collaborative research and health care sector reform in developing countries. The second part is the Chinese version of his representative paper titled as ＂ Disease Surveillance, Benefit and Sample Sharing＂. In this paper he examined the controversy within the WHO to establish a framework for pandemic influenza preparedness. The controversy was over what benefits those who contributed samples could expect in return, in particular in terms of access to pandemic vaccines. Agreement was reached in 2011, although the underlying controversial issues remain unresolved. In the third part, he answered questions concerning the relationship between bioethics and philosophy of science, the normative nature of bioethics and the requirement of bioethieists of understanding the actual issues in clinical and research practices.